How to appeal a EmblemHealth continuous glucose monitors & insulin pumps denial
ACA §2719 + ERISA §503 · 180-day window · 30-day decision
The framework that applies to your appeal
Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.
EmblemHealth-specific note: NY-based; operates HIP (HMO) and GHI (PPO) brands; ~3M members. Administers the NYC municipal employee GHI-CBP plan — high-volume source of OON disputes for retirees. NY DFS oversight; ConnectiCare is the Connecticut subsidiary.
What EmblemHealth typically denies for continuous glucose monitors & insulin pumps
Across EmblemHealth's commercial and Medicare books, denials cluster around a small number of patterns. For continuous glucose monitors & insulin pumps, expect:
- HIP HMO referral denials
- GHI PPO out-of-network reductions (NYC municipal employee plan)
- Behavioral health prior auth
- Specialty drug PA
Treatments most often denied in this category
These are the continuous glucose monitors & insulin pumps treatments most often flagged for prior auth, step therapy, or medical necessity review:
- Dexcom G7
- Dexcom G6
- Libre 3 Plus
- Libre 2 Plus
- Eversense 365
- Tandem t:slim X2
How to submit the appeal to EmblemHealth
- Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
- Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document EmblemHealth cited in the denial.
- File the appeal through EmblemHealth's portal (members: https://www.emblemhealth.com ; providers: https://www.emblemhealth.com/providers). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
- If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In NY, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.
Frequently asked questions
How long do I have to appeal a EmblemHealth continuous glucose monitors & insulin pumps denial?
EmblemHealth allows 180 days from the date on the denial letter to file an internal appeal. Standard decisions come back within 30 days; expedited decisions for urgent care typically within 72 hours.
What's the fastest way to submit a EmblemHealth appeal?
Members can submit through the EmblemHealth member portal at https://www.emblemhealth.com. Providers should use the provider portal at https://www.emblemhealth.com/providers. Faxed and mailed appeals are accepted but take longer.
What denials does EmblemHealth most often issue for continuous glucose monitors & insulin pumps?
Across EmblemHealth's book of business the common patterns include: HIP HMO referral denials; GHI PPO out-of-network reductions (NYC municipal employee plan); Behavioral health prior auth. For continuous glucose monitors & insulin pumps specifically, expect denials tied to the FDA-approved indication, step therapy through cheaper alternatives, and prior authorization documentation gaps.
What if EmblemHealth denies the appeal too?
After an internal appeal denial you have the right to an external review by an independent reviewer (IRO) — request it within 4 months of the final internal denial.
Start your Continuous glucose monitors & insulin pumps appeal
Upload your EmblemHealth denial letter — DenialHelp drafts a physician-ready appeal in five minutes, aligned to ACA §2719 + ERISA §503.
Get started →Contact: hello@denialhelp.com